Free Trial

Vera Therapeutics (VERA) SEC Filings & 10K Form

Vera Therapeutics logo
$28.58 -1.03 (-3.48%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$29.29 +0.71 (+2.48%)
As of 02/21/2025 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Vera Therapeutics SEC Filings

DateFilerForm TypeView
02/20/2025
3:05 PM
JOHNSON DAVID LEE (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
3:07 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
3:08 PM
Grant Sean (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
3:10 PM
Brenner Robert (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
8:30 AM
Avoro Capital Advisors LLC (Filed by)
Vera Therapeutics (Subject)
Form SCHEDULE 13G/A
01/13/2025
7:06 AM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:22 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2024
3:24 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
3:59 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
3:05 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:40 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
11:15 AM
Kynam Capital Management, LP (Filed by)
Vera Therapeutics (Subject)
Form SC 13G/A
11/14/2024
8:35 AM
Avoro Capital Advisors LLC (Filed by)
Vera Therapeutics (Subject)
Form SC 13G
11/12/2024
9:34 AM
FMR LLC (Filed by)
Vera Therapeutics (Subject)
Form SC 13G/A
11/07/2024
7:00 AM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
6:49 PM
Longitude Capital Partners IV, LLC (Filed by)
Vera Therapeutics (Subject)
Form SC 13D/A
10/31/2024
5:05 AM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
3:15 PM
Vera Therapeutics (Filer)
Form 424B5
10/29/2024
5:15 AM
Vera Therapeutics (Filer)
Form 424B5
10/28/2024
4:29 PM
Vera Therapeutics (Filer)
Form S-3ASR
10/28/2024
4:30 PM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
3:37 PM
SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2024
3:16 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/11/2024
3:05 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2024
3:17 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2024
8:01 AM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
3:05 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
3:45 PM
SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:38 PM
SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:38 PM
SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2024
3:36 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:19 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
3:04 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
4:40 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
3:31 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
3:24 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/08/2024
3:36 PM
Vera Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
7:00 AM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2024
4:15 PM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:30 AM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
8:27 PM
Grant Sean (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Elon’s “New Gold” (Ad)

MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology. It’s so valuable that some are referring to it as the “new gold”.

I reveal all of the details here.
04/05/2024
8:32 PM
Grant Sean (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
8:55 PM
Vera Therapeutics (Filer)
Form ARS
04/03/2024
4:00 PM
Vera Therapeutics (Filer)
Form DEF 14A
04/03/2024
4:02 PM
Vera Therapeutics (Filer)
Form DEFA14A
03/26/2024
7:35 PM
Vera Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
6:57 PM
Sofinnova Venture Partners X, L.P. (Filed by)
Vera Therapeutics (Subject)
Form SC 13D/A
03/25/2024
8:46 PM
Katabi Maha (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
3:54 PM
Katabi Maha (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2024
6:30 AM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VERA) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners